Insufflation Pressure for Postoperative Pain
Trial Summary
What is the purpose of this trial?
The purpose of this study is to determine the effect of decreased insufflation pressure on postoperative pain, analgesic use, and surgical safety and feasibility for laparoscopic hysterectomy.
Do I need to stop my current medications for this trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What data supports the effectiveness of the treatment Lower Insufflation Pressure for reducing postoperative pain?
Is low insufflation pressure safe for humans during surgery?
How does the treatment of lower insufflation pressure differ from other treatments for postoperative pain?
Lower insufflation pressure, used during surgeries like laparoscopic procedures, is unique because it reduces the pressure of the gas used to inflate the abdomen, which can lead to less postoperative pain and shorter hospital stays without increasing surgery time or blood loss. This approach is a simple, low-cost intervention that improves patient comfort and recovery.13456
Research Team
Eligibility Criteria
This trial is for individuals undergoing laparoscopic hysterectomy, a minimally invasive surgery to remove the uterus. Participants must meet certain health criteria set by the researchers but these specific requirements are not provided in the given information.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Preoperative Assessment
Participants' preoperative pain is assessed using the Visual Analog Scale (VAS) within 2 hours before surgery
Treatment
Participants undergo laparoscopic hysterectomy with either 12 mmHg or 15 mmHg insufflation pressure
Immediate Postoperative
Participants' pain is assessed using the VAS in the post anesthesia care unit (PACU) approximately 2 hours after surgery
Postoperative Day 1
Participants' pain is assessed using the VAS approximately 24 hours after surgery
Follow-up
Participants are monitored for postoperative pain and opioid use at a follow-up visit 2 weeks after surgery
Treatment Details
Interventions
- Lower Insufflation Pressure (Procedure)
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Tennessee
Lead Sponsor
Larry Dillaha
University of Tennessee
Chief Executive Officer since 2021
MD from the University of Tennessee, Memphis
Robert Elfont
University of Tennessee
Chief Medical Officer since 2021
MD, PhD